Seroprevalence of anti-rubella IgM antibody among pregnant and childbearing women in Diyala province

Abdul-Razak SH. Hasan
College of Medicine, Diyala University, Diyala, Iraq
Abbas A. Al-Duliami
College of Education, Diyala University, Diyala, Iraq
Adnan A. Neima
College of Education, Diyala University, Diyala, Iraq
Asmma H. Al-Jurani
College of Education, Diyala University, Diyala, Iraq
Share:
  • Articles
  • Submited: November 6, 2018
  • Published: November 6, 2018

Abstract

Background and Objective: Rubella infections acquired postnatally are usually mild, but maternal infection during pregnancy is associated with considerable risk of intrauterine fetal infection with multi-system damage.Detection of anti-rubella IgM specific antibodies among pregnant and childbearing women in Baquba city and to explore the effects of   certain demographic factors.

Methods: The present study was conducted in Baquba-Diyala province during the period from April/2007 to September/2008. Ninety pregnant women were chosen from those   attending the primary health care centers in Baquba. They include 30(33.3%) pregnant women who had previous abortions with a mean age 27.2 ± 5.3 years, and 60(66.7%) pregnant women without previous abortion with mean age 23.7± 5.1 years. Additionally, 94 non-pregnant childbearing women were enrolled as a control group. Of those, 37(39.4%) had previous abortions with mean age 33.5 ± 7.8 years, and 57 (60.6%) without abortion, the mean age was 30.7±7.8 years. Certain demographic factors were collected by personal interview. Anti-rubella IgM specific antibody was detected by enzyme-linked immunosorbant assay (ELISA). Data were statistically analyzed using SPSS computer   assisted processing. P value of < 0.05 was considered significant.

Results: The results revealed that 3(5%) of pregnant women without previous abortion and 8(26.7%) of pregnant women who had previous abortions were seropositive for anti-rubella IgM antibody. The difference between the two groups was statistically significant (p= 0.003).Whereas, the IgM seropositivity was insignificantly higher in childbearing women without previous abortion compared to childbearing women who had previous abortions (24.6% vs 16.2%), (p=0.33). Furthermore, the IgM seropositivity among childbearing women without previous abortion was significantly higher compared to pregnant women without previous abortion (24.6% vs 5%), (p=0.003).The presence of life births, time of gestation, and the levels of education significantly affect the seropositivity rate of IgM.

Conclusions: Prenatal screening for anti-rubella IgM antibody is an important tool to identify active infection and to provide obstetric management to avoid the risk of congenital rubella syndrome.

Metrics

Metrics Loading ...

References

  1. Grangeot-Keros, L. Rubella and pregnancy. Pathol. Biol. 1992; 40 (7): 706-10.
  2. Brooks, G.F.; Carroll, K.C.; Butel, J.S. and Morse, S.A. Paramyxoviruses and rubella virus.In: Medical Microbiology. 24th. Ed. 2007. McGraw-Hill. 546-566.
  3. Sharquie, K.E. and Al-Rawi, J.R. Clinical study of rubella in Baghdad. Iraqi J. Comm. Med. 2002; 15(4): 52-7.
  4. Tamer, G.S.; Dundar, D.; Callskan, E. Seroprevalence of toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin. Invest. Med. 2009; 32(1): 43-7.
  5. Ahmed, M.U. IgM and IgG antibodies specific to rubella in childbearing women. J. Pak. Med. Assoc. 1992; 42(5): 121-2.
  6. Das, S.; Ramachandran, V.G. and Arora, R. Cytomegalovirus and rubella infection in children and pregnant mothers: A hospital based study. Commun. Dis. 2007; 39(2): 113-7.
  7. Yasodhara, P.; Ramalakshmi B.A.; Naidu, A.N. and Raman, L. Prevalence of specific IgM due to toxoplama, rubella, CMV and C. trachomatis infections during pregnancy. Indian J. Med. Microbiol. 2001; 19(2): 52-6.
  8. Rajasundari, T.A.; Chandrasekar, K.; Vijayalakshmi, P. and Muthukkauppan, V. Immune status of health care personnel and post-vaccination analysis of immunity against rubella in an eye hospital. Indian J. Med. Res. 2006; 124:553-8.
  9. Zgorniak-Nowosielsk, I.; Zawilinska, B. and Szostek, S. Rubella infection during pregnancy in the 1985-1986 epidemics: Follow-up after seven years. Europ. J. Epidemiol. 1996; 12(3): 303-308.
  10. Ghazi, H.O. Prevalence of IgG and IgM antibodies to rubella in Saudi pregnant women. Saudi Med. J. 1999; 3: 279-83.
  11. Ocak, S.; Zeteroglu, S.; Ozer, C.; et al. Seroprevalence of toxoplasma gondii, rubella, cytomegalovirus among pregnant women in Southern Turkey. Scand. J. Infect. Dis. 2007; 39(3):231-34.
  12. Reiche,E.M.; Morimoto, H.K.; Farias, G.N.; Hisatsugu, K.R.; Geller, L.; et al. Prevalence of American trypanosomiasis, syphilis, toxoplasmosis, rubella, hepatitis B, hepatitis C and human immunodeficiency virus infections assayed through serological tests among pregnant patients from 1996 to 1998 at the regional University Hospital. Rev.Soc.Bras. Med. Trop. 2000;23(10): 780-7.
  13. Li,Z.; Yan, C.; Liu, P.;Yan, R. and Feng, Z. Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing. Clin. Chim. Acta. 2009; 403(1-2): 212-5.
  14. El-Mekki, A.A. and Zeki, Z.M. Screening for rubella antibodies among Saudi women of childbearing age. Saudi Med. J. 1998; 19(5): 575-77.
  15. Zheng, F.; Du, J. and Hu,Y. A study of rubella virus infection during pregnancy. Zhonghau Fu. Chan. Ke Za. Zhi. 2002; 37(3): 391-4.
  16. Al-Zubaidy, A.H. Rubella and CMV infection in Iraqi pregnant and aborted females and those congenitally malformed children: A retrospective study. M.Sc. thesis. Saddam College of Medicine-Baghdad.
  17. Lateef, I.I. Rubella and congenital rubella infection in Baghdad. M.Sc. thesis. Saddam College of Medicine-Baghdad.
  18. Abood,A.S.; Ahmed, H.T. and Hamid, A.N. Is estimation of the rubella serum antibody level of the women before marriage justified? J. Islamic Acad. Sci.1995; 8(3): 127-30.
  19. Banatvala J.E. and Brown, D.W. Rubella. Lancet, 2004; 363: 1127-37.
  20. De Santis, M.; Cavaliere, A.F.; Straface, G. and Caruso, A. Rubella infection in pregnancy. Reprod. Toxicol. 2006; 21(4): 390-8.
  21. Morice, A.; Rolando U.; Avila, M.M. Congenital rubella syndrome: Progress and future challage. Expert Rev. Vaccines, 2009; 8(3): 323-31.
  22. Aboudy Y.; Fogel A.; Barnea B.; Mendelson E.; Yosef L.; Frank T. and Shalev E. Subclinical rubella reinfection during pregnancy followed by transmission of the virus to the fetus. J. infect. 1997; 34(3): 273-6.
  23. Reef, S.E.; Redd, S.B.; Abernathy, E.; Zimmerman, L. and Icenogle, J.P. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission. Clin. Infect. Dis. 2006; 43(suppl.3): 126-32.
How to Cite
Hasan, A.-R. S., Al-Duliami, A. A., Neima, A. A., & Al-Jurani, A. H. (2018). Seroprevalence of anti-rubella IgM antibody among pregnant and childbearing women in Diyala province. Zanco Journal of Medical Sciences (Zanco J Med Sci), 14(1 Special), 195–200. Retrieved from https://zjms.hmu.edu.krd/index.php/zjms/article/view/576

Send mail to Author


Send Cancel